AnalystsMatthew AndrewsMatthew Andrews's Stock Forecasts
AnalystsMatthew Andrews
Sectors:
Industries:
Analyst Ranking
Bottom 16%
#3868 out of 4573 analysts
Average Return
-19.3%
Win Rate
50%3 out of 6
Risk vs Reward
Poor
Good
Matthew Andrews's 5 best and worst ratings
Matthew Andrews Analyst Color
Get additional color on Matthew Andrews's coverage of popular stocks
Matthew Andrews's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cara Therapeutics IncCARA | 2 | Strong Buy | $22.00 | N/A | Assumes | 5 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Strong Buy | $22.00 | N/A | Assumes | 5 years ago |
Cti Biopharma CorpCTIC | 1 | Strong Buy | $7.50 | N/A | Initiates Coverage On | 7 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 7 years ago |
Aevi Genomic Medicine IncGNMX | 1 | Hold | $2.50 | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.